(AEON) AEON Biopharma - Performance -99% in 12m
AEON performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-73.62%
#110 in Peer-Group
Rel. Strength
0.13%
#7405 in Stock-Universe
Total Return 12m
-98.99%
#201 in Peer-Group
Total Return 5y
-99.89%
#195 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 0.00 |
| P/E Forward | 1.16 |
| High / Low | USD |
|---|---|
| 52 Week High | 210.96 USD |
| 52 Week Low | 0.40 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 74.83 |
| Buy/Sell Signal +-5 | 0.57 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AEON (-99%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: AEON vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AEON
| Total Return (including Dividends) | AEON | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 38.03% | 2.09% | 4.55% |
| 3 Months | 31.15% | 2.27% | 10.78% |
| 12 Months | -98.99% | -10.84% | 14.71% |
| 5 Years | -99.89% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | AEON | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 19.5% | 18.8% | 79.2% |
| 3 Months | 79.9% | 71.5% | 92.9% |
| 12 Months | -91.4% | -84.3% | 44.2% |
| 5 Years | -76.2% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th95.50 | 35.21% | 32.02% |
| 3 Month | %th83.00 | 28.24% | 18.39% |
| 12 Month | %th0.00 | -98.86% | -99.12% |
| 5 Years | %th2.50 | -99.83% | -99.93% |
FAQs
Does AEON Biopharma (AEON) outperform the market?
No,
over the last 12 months AEON made -98.99%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months AEON made 31.15%, while XBI made 2.27%.
Performance Comparison AEON vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AEON vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.5% | 33.5% | -104.1% | -114% |
| US NASDAQ 100 | QQQ | 3.7% | 32.5% | -106.2% | -114% |
| German DAX 40 | DAX | 4.7% | 38% | -117% | -129% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.8% | 33.9% | -102.1% | -117% |
| Hongkong Hang Seng | HSI | 4.9% | 32.2% | -119.8% | -135% |
| India NIFTY 50 | INDA | 4.9% | 35.9% | -103.8% | -99% |
| Brasil Bovespa | EWZ | 3.1% | 30.3% | -128.6% | -112% |
AEON vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3% | 31.3% | -110.8% | -128% |
| Consumer Discretionary | XLY | 6.1% | 36.4% | -95.4% | -119% |
| Consumer Staples | XLP | 8% | 39.7% | -102.3% | -108% |
| Energy | XLE | 8.9% | 34.5% | -98.6% | -95% |
| Financial | XLF | 4.4% | 35% | -107.2% | -128% |
| Health Care | XLV | 5.5% | 36% | -96.9% | -94% |
| Industrial | XLI | 4.9% | 34.3% | -110.7% | -123% |
| Materials | XLB | 6.4% | 36.4% | -103.4% | -102% |
| Real Estate | XLRE | 9% | 38% | -101.5% | -112% |
| Technology | XLK | 3.2% | 29.1% | -107.3% | -111% |
| Utilities | XLU | 6.9% | 38% | -107.5% | -123% |
| Aerospace & Defense | XAR | 2.6% | 28.2% | -125.5% | -152% |
| Biotech | XBI | 6.6% | 35.9% | -90.2% | -88% |
| Homebuilder | XHB | 6.2% | 32% | -92.8% | -100% |
| Retail | XRT | 7.6% | 36.6% | -95.4% | -105% |
AEON vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 11.8% | 32.9% | -94.8% | -89% |
| Natural Gas | UNG | 16.7% | 47.5% | -89% | -91% |
| Gold | GLD | 9.5% | 40.2% | -124% | -140% |
| Silver | SLV | 7.9% | 34.2% | -122.7% | -121% |
| Copper | CPER | 4.2% | 33.9% | -123.8% | -114% |
AEON vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.7% | 34.4% | -100.9% | -101% |
| iShares High Yield Corp. Bond | HYG | 6.6% | 36.2% | -103.1% | -110% |